Zyad Chaudhary
Neurology · Toledo, OHNPI 1922365584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,832 and has fallen 90.2% since, to $180 in 2025.
Across 110 payments — averaging $49.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$604
- AstraZeneca$581
- Biogen$519
- Nevro Corp.$395
- Sunovion Pharmaceuticals Inc.$342
- Saluda Medical Americas, Inc.$300
- plus $3K from 32 others
What the payments were for
- Travel & lodging$60%
- Food & beverage$5,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $604 |
| AstraZeneca(2 entities) | 7 | $581 |
| Biogen | 8 | $519 |
| Nevro Corp. | 5 | $395 |
| Sunovion Pharmaceuticals Inc. | 4 | $342 |
| Saluda Medical Americas, Inc. | 3 | $300 |
| E.r. Squibb & Sons, L.L.C. | 4 | $264 |
| SPR Therapeutics, Inc | 2 | $260 |
| Medtronic | 4 | $229 |
| CSL Behring | 2 | $206 |
| EMD Serono, Inc. | 3 | $189 |
| Abbott | 7 | $177 |
| Heron Therapeutics, Inc. | 2 | $150 |
| Johnson & Johnson(2 entities) | 4 | $132 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| Argenx US, Inc. | 3 | $115 |
| Novartis | 6 | $112 |
| UCB, Inc. | 4 | $111 |
| Pfizer | 1 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $67 |
| Shire North American Group Inc | 1 | $55 |
| Amneal Pharmaceuticals LLC | 1 | $47 |
| Stryker | 1 | $47 |
| Livanova USA, Inc. | 3 | $43 |
| Chiesi USA, Inc. | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 1 | $38 |
| Biotronik NRO, Inc. | 1 | $33 |
| Irhythm Technologies, Inc. | 1 | $28 |
| TG Therapeutics, Inc. | 1 | $25 |
| SK Life Science, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| BD | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$281
- Evoke SCS$278
- ULTOMIRIS$252
- BOTOX$227
- SPRINT PNS System$180
- INTELLIS ADAPTIVESTIM$164
- FARXIGA$125
- LONHALA MAGNAIR$125
- Mavenclad$125
- XARELTO$122
- UBRELVY$116
- Hizentra$115
- APTIOM$111
- ADUHELM$110
- TRUMENBA$103
How this compares
$5,499 in reported general payments places this provider in the 70th percentile of 702 neurology providers in Ohio.
Other neurology in Toledo
- Lawrence ElmerToledo$687K
- Faizan HafeezToledo$337K
- Howard SchechtToledo$183K
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.